In a study using skin fibroblasts from MS patients, it was observed that there was increased gene expression in the ATF4/CHOP axis (69), leading us to speculate that the upregulation of ATF4 and eIf2a is an important contributor to MS. This evidence concerns the gene EIF2A and myeloid sarcoma.